Pharmacological validation of the free-exploratory paradigm in Wistar rats : a proposed test of trait anxiety

Souza, Thiago Henrique Almeida

Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/6857

Registro completo de metadados

Campo DC	Valor	Idioma
dc.contributor.author	Souza, Thiago Henrique Almeida	-
dc.date.accessioned	2017-11-06T12:43:17Z	-
dc.date.available	2017-11-06T12:43:17Z	-
dc.date.issued	2014-09-22	-
dc.identifier.citation	SOUZA, Thiago Henrique Almeida. Pharmacological validation of the free-exploratory paradigm in Wistar rats : a proposed test of trait anxiety. 2015. 1 CD-ROM Monografia (Bacharelado em Farmácia) - Departamento de Farmácia, Centro de Ciências Biológicas e da saúde, Universidade Federal de Sergipe, São Cristóvão, SE, 2015.	pt_BR
dc.identifier.uri	https://ri.ufs.br/handle/riufs/6857	-
dc.language	por	pt_BR
dc.subject	Farmácia	por
dc.subject	Ensino de farmácia	por
dc.title	Pharmacological validation of the free-exploratory paradigm in Wistar rats : a proposed test of trait anxiety	pt_BR
dc.type	Monografia	pt_BR
dc.contributor.advisor1	Silva, Flávia Teixeira	-
dc.description.resumo	The free-exploratory paradigm (FEP) has been proposed as a model of trait anxiety for both mice and rats. However, its pharmacological validation has only been carried out for mice. Thus, the aim of the present study was to pharmacologically validate FEP for Wistar rats, by testing the effects of clinically established anxiolytic and anxiogenic drugs, in four different experiments. In all experiments, male Wistar rats were first tested in FEP to be categorized according to their levels of trait anxiety (high, medium and low). Then, only medium trait anxiety rats were selected to be tested again in FEP, two weeks later, after being pharmacologically treated, according to each experiment as follows: Experiment I: 0.5 mg/kg of diazepam (DZP) or vehicle; Experiment II: 20 mg/kg of pentylenetetrazole (PTZ) or vehicle; Experiment III: 5 mg/kg of fluoxetine (FLX5) or vehicle: and Experiment IV: 0.5 mg/kg of fluoxetine (FLX0.5) or vehicle. As a group, the results showed that PTZ and FLX5 increased levels of trait anxiety and reduced locomotor activity, whereas DZP and FLX0.5 decreased levels of trait anxiety, without impairing locomotor activity. These results demonstrate that FEP for rats is able to predict clinical anxiolytic and anxiogenic activities of different drugs, including fluoxetine, which is believed to present a dual effect on anxiety. Therefore, this paradigm can be proposed as an effective method for testing potential trait anxiety-reducing drugs, in rats.	pt_BR
dc.publisher.department	DFA - Departamento de Farmácia – São Cristóvão - Presencial	pt_BR
dc.publisher.initials	Universidade Federal de Sergipe	pt_BR
dc.description.local	São Cristóvão, SE	pt_BR
Aparece nas coleções:	Farmácia

Arquivos associados a este item:

Arquivo	Descrição	Tamanho	Formato
Thiago Henrique Almeida Souza.pdf		290,88 kB	Adobe PDF	Visualizar/Abrir

Mostrar registro simples do item Visualizar estatísticas